Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO

Journal of Immunology

Volumn 189, Issue 8, 2012, Pages 3848-3858

  Sumpter, Tina L ^a,b   Dangi, Anil ^a,c   Matta, Benjamin M ^a,b   Huang, Chao ^a,c   Stolz, Donna B ^b   Vodovotz, Yoram ^a   Thomson, Angus W ^a,b   Gandhi, Chandrashekhar R ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGRAMMED DEATH 1 LIGAND 1; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL CONTACT; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL POPULATION; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INDUCTION; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STEADY STATE; STELLATE CELL; T LYMPHOCYTE; TRANSCRIPTION INITIATION; UPREGULATION;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DOWN-REGULATION; ENZYME INDUCTION; HEPATIC STELLATE CELLS; IMMUNOPHENOTYPING; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; ISOANTIGENS; LIVER; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELOID CELLS; STAT3 TRANSCRIPTION FACTOR;

EID: 84867298004     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200819     Document Type: Article

References (85)

1. Crispe, I. N. 2009. The liver as a lymphoid organ. Annu. Rev. Immunol. 27: 147-163.
2. Thomson, A. W., and P. A. Knolle. 2010. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 10: 753-766.
3. Calne, R. Y., R. A. Sells, J. R. Pena, D. R. Davis, P. R. Millard, B. M. Herbertson, R. M. Binns, and D. A. Davies. 1969. Induction of immunological tolerance by porcine liver allografts. Nature 223: 472-476.
4. Qian, S., A. J. Demetris, N. Murase, A. S. Rao, J. J. Fung, and T. E. Starzl. 1994. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 19: 916-924. (Pubitemid 24109354)
5. Mazariegos, G. V., J. Reyes, I. R. Marino, A. J. Demetris, B. Flynn, W. Irish, J. McMichael, J. J. Fung, and T. E. Starzl. 1997. Weaning of immunosuppression in liver transplant recipients. Transplantation 63: 243-249. (Pubitemid 27121206)
6. Takatsuki, M., S. Uemoto, Y. Inomata, H. Egawa, T. Kiuchi, S. Fujita, M. Hayashi, T. Kanematsu, and K. Tanaka. 2001. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 72: 449-454. (Pubitemid 32769631)
7. Sánchez-Fueyo, A., and T. B. Strom. 2011. Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology 140: 51-64.
8. Feng, S., U. D. Ekong, S. J. Lobritto, A. J. Demetris, J. P. Roberts, P. Rosenthal, E. M. Alonso, M. C. Philogene, D. Ikle, K. M. Poole, et al. 2012. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 307: 283-293.
9. Bamboat, Z. M., L. M. Ocuin, V. P. Balachandran, H. Obaid, G. Plitas, and R. P. DeMatteo. 2010. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J. Clin. Invest. 120: 559-569.
10. Tsung, A., N. Zheng, G. Jeyabalan, K. Izuishi, J. R. Klune, D. A. Geller, M. T. Lotze, L. Lu, and T. R. Billiar. 2007. Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J. Leukoc. Biol. 81: 119-128. (Pubitemid 46021260)
11. Sumpter, T. L., M. Abe, D. Tokita, and A. W. Thomson. 2007. Dendritic cells, the liver, and transplantation. Hepatology 46: 2021-2031.
12. Connolly, M. K., A. S. Bedrosian, J. Mallen-St Clair, A. P. Mitchell, J. Ibrahim, A. Stroud, H. L. Pachter, D. Bar-Sagi, A. B. Frey, and G. Miller. 2009. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J. Clin. Invest. 119: 3213-3225.
13. Jiao, J., D. Sastre, M. I. Fiel, U. E. Lee, Z. Ghiassi-Nejad, F. Ginhoux, E. Vivier, S. L. Friedman, M. Merad, and C. Aloman. 2012. Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression. Hepatology 55: 244-255.
14. Morelli, A. E., and A. W. Thomson. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7: 610-621. (Pubitemid 47123548)
15. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161. (Pubitemid 37336516)
16. Liu, K., and M. C. Nussenzweig. 2010. Origin and development of dendritic cells. Immunol. Rev. 234: 45-54.
17. Tokita, D., T. L. Sumpter, G. Raimondi, A. F. Zahorchak, Z. Wang, A. Nakao, G. V. Mazariegos, M. Abe, and A. W. Thomson. 2008. Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells. J. Hepatol. 49: 1008-1018.
18. Bamboat, Z. M., J. A. Stableford, G. Plitas, B. M. Burt, H. M. Nguyen, A. P. Welles, M. Gonen, J. W. Young, and R. P. DeMatteo. 2009. Human liver dendritic cells promote T cell hyporesponsiveness. J. Immunol. 182: 1901-1911.
19. Sumpter, T. L., V. Packiam, H. R. Turnquist, A. Castellaneta, O. Yoshida, and A. W. Thomson. 2011. DAP12 promotes IRAK-M expression and IL-10 production by liver myeloid dendritic cells and restrains their T cell allostimulatory ability. J. Immunol. 186: 1970-1980.
20. Abe, M., D. Tokita, G. Raimondi, and A. W. Thomson. 2006. Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses. Eur. J. Immunol. 36: 2483-2493. (Pubitemid 44420604)
21. Lunz, J. G., III, S. M. Specht, N. Murase, K. Isse, and A. J. Demetris. 2007. Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity. Hepatology 46: 1946-1959.
22. Mashreghi, M. F., R. Klemz, I. S. Knosalla, B. Gerstmayer, U. Janssen, R. Buelow, A. Jozkowicz, J. Dulak, H. D. Volk, and K. Kotsch. 2008. Inhibition of dendritic cell maturation and function is independent of heme oxygenase 1 but requires the activation of STAT3. J. Immunol. 180: 7919-7930.
23. Wölfle, S. J., J. Strebovsky, H. Bartz, A. Sähr, C. Arnold, C. Kaiser, A. H. Dalpke, and K. Heeg. 2011. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur. J. Immunol. 41: 413-424.
24. Sun, Y., Y. E. Chin, E. Weisiger, C. Malter, I. Tawara, T. Toubai, E. Gatza, P. Mascagni, C. A. Dinarello, and P. Reddy. 2009. Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3. J. Immunol. 182: 5899-5903.
25. Laurence, J. M., C. Wang, E. T. Park, A. Buchanan, A. Clouston, R. D. Allen, G. W. Mccaughan, G. A. Bishop, and A. F. Sharland. 2008. Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents longterm survival but does not cause acute rejection. Transplantation 85: 1357-1361. (Pubitemid 351670489)
26. Wang, C., S. S. Tay, G. T. Tran, S. J. Hodgkinson, R. D. Allen, B. M. Hall, G. W. McCaughan, A. F. Sharland, and G. A. Bishop. 2010. Donor IL-4-treatment induces alternatively activated liver macrophages and IDOexpressing NK cells and promotes rat liver allograft acceptance. Transpl. Immunol. 22: 172-178.
27. Lin, Y. C., C. L. Chen, T. Nakano, S. Goto, Y. H. Kao, L. W. Hsu, C. Y. Lai, B. Jawan, Y. F. Cheng, C. Tateno, and K. Yoshizato. 2008. Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance. J. Gastroenterol. Hepatol. 23: e243-e250. (Pubitemid 352019410)
28. Heller, M. C., C. P. Drew, K. A. Jackson, S. Griffey, and J. L. Watson. 2010. A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection. Vet. Immunol. Immunopathol. 138: 174-182.
29. Friedman, S. L. 2000. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275: 2247-2250. (Pubitemid 30081976)
30. Geerts, A. 2001. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin. Liver Dis. 21: 311-335. (Pubitemid 32923763)
31. Pinzani, M., and F. Marra. 2001. Cytokine receptors and signaling in hepatic stellate cells. Semin. Liver Dis. 21: 397-416. (Pubitemid 32923768)
32. Gandhi, C. 2011. Hepatic stellate cells. In Molecular Pathology of Liver Diseases. S. P. S. Monga, ed. Springer, New York, p. 53-80.
33. Winau, F., G. Hegasy, R. Weiskirchen, S. Weber, C. Cassan, P. A. Sieling, R. L. Modlin, R. S. Liblau, A. M. Gressner, and S. H. Kaufmann. 2007. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26: 117-129. (Pubitemid 46109346)
34. Yu, M. C., C. H. Chen, X. Liang, L. Wang, C. R. Gandhi, J. J. Fung, L. Lu, and S. Qian. 2004. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 40: 1312-1321. (Pubitemid 39657005)
35. Jiang, G., H. R. Yang, L. Wang, G. M. Wildey, J. Fung, S. Qian, and L. Lu. 2008. Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation 86: 1492-1502.
36. Ichikawa, S., D. Mucida, A. J. Tyznik, M. Kronenberg, and H. Cheroutre. 2011. Hepatic stellate cells function as regulatory bystanders. J. Immunol. 186: 5549-5555.
37. Chinnadurai, R., and A. Grakoui. 2010. B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells. Hepatology 52: 2177-2185.
38. Schildberg, F. A., A. Wojtalla, S. V. Siegmund, E. Endl, L. Diehl, Z. Abdullah, C. Kurts, and P. A. Knolle. 2011. Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism. Hepatology 54: 262-272.
39. Dangi, A., T. L. Sumpter, S. Kimura, D. B. Stolz, N. Murase, G. Raimondi, Y. Vodovotz, C. Huang, A. W. Thomson, and C. R. Gandhi. 2012. Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance. J. Immunol. 188: 3667-3677.
40. Thirunavukkarasu, C., S. C. Watkins, and C. R. Gandhi. 2006. Mechanisms of endotoxin-induced NO, IL-6, and TNF-alpha production in activated rat hepatic stellate cells: role of p38 MAPK. Hepatology 44: 389-398. (Pubitemid 44214878)
41. Woo, J., L. Lu, A. S. Rao, Y. Li, V. Subbotin, T. E. Starzl, and A. W. Thomson. 1994. Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation 58: 484-491. (Pubitemid 24271538)
42. Matsuno, K., T. Ezaki, S. Kudo, and Y. Uehara. 1996. A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J. Exp. Med. 183: 1865-1878. (Pubitemid 26134327)
43. Hellerbrand, S. C., S. C. Wang, H. Tsukamoto, D. A. Brenner, and R. A. Rippe. 1996. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 24: 670-676. (Pubitemid 26296014)
44. Yang, D., Q. Chen, D. M. Hoover, P. Staley, K. D. Tucker, J. Lubkowski, and J. J. Oppenheim. 2003. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J. Leukoc. Biol. 74: 448-455. (Pubitemid 38040406)
45. Nakayama, T., J. Shirane, K. Hieshima, M. Shibano, M. Watanabe, Z. Jin, D. Nagakubo, T. Saito, Y. Shimomura, and O. Yoshie. 2006. Novel antiviral activity of chemokines. Virology 350: 484-492. (Pubitemid 43928115)
46. Steinbrink, K., M. Wölfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159: 4772-4780.
47. Park, S. J., T. Nakagawa, H. Kitamura, T. Atsumi, H. Kamon, S. Sawa, D. Kamimura, N. Ueda, Y. Iwakura, K. Ishihara, et al. 2004. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 173: 3844-3854. (Pubitemid 39280747)
48. Sheikh, N. A., and L. A. Jones. 2008. CD54 is a surrogate marker of antigen presenting cell activation. Cancer Immunol. Immunother. 57: 1381-1390.
49. Pillarisetty, V. G., A. B. Shah, G. Miller, J. I. Bleier, and R. P. DeMatteo. 2004. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J. Immunol. 172: 1009-1017. (Pubitemid 38113760)
50. Xu, L. L., M. K. Warren, W. L. Rose, W. Gong, and J. M. Wang. 1996. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J. Leukoc. Biol. 60: 365-371. (Pubitemid 26325618)
51. Rescigno, M., V. Piguet, B. Valzasina, S. Lens, R. Zubler, L. French, V. Kindler, J. Tschopp, and P. Ricciardi-Castagnoli. 2000. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J. Exp. Med. 192: 1661-1668.
52. Lundqvist, A., T. Nagata, R. Kiessling, and P. Pisa. 2002. Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L). Cancer Immunol. Immunother. 51: 139-144. (Pubitemid 34298109)
53. Guo, Z., M. Zhang, H. An, W. Chen, S. Liu, J. Guo, Y. Yu, and X. Cao. 2003. Fas ligation induces IL-1beta-dependent maturation and IL-1beta-independent survival of dendritic cells: different roles of ERK and NF-kappaB signaling pathways. Blood 102: 4441-4447. (Pubitemid 37494108)
54. Saile, B., T. Knittel, N. Matthes, P. Schott, and G. Ramadori. 1997. CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am. J. Pathol. 151: 1265-1272. (Pubitemid 27479756)
55. Jonuleit, H., U. Kühn, G. Müller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, and A. H. Enk. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27: 3135-3142.
56. Castiello, L., M. Sabatino, P. Jin, C. Clayberger, F. M. Marincola, A. M. Krensky, and D. F. Stroncek. 2011. Monocyte-derived DC maturation strategies and related pathways: a transcriptional view. Cancer Immunol. Immunother. 60: 457-466.
57. Chen, L. 2004. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4: 336-347. (Pubitemid 38649276)
58. Orabona, C., M. L. Belladonna, C. Vacca, R. Bianchi, F. Fallarino, C. Volpi, S. Gizzi, M. C. Fioretti, U. Grohmann, and P. Puccetti. 2005. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. J. Immunol. 174: 6582-6586. (Pubitemid 40705617)
59. Orabona, C., M. T. Pallotta, C. Volpi, F. Fallarino, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, U. Grohmann, and P. Puccetti. 2008. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis. Proc. Natl. Acad. Sci. USA 105: 20828-20833.
60. Munn, D. H., E. Shafizadeh, J. T. Attwood, I. Bondarev, A. Pashine, and A. L. Mellor. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189: 1363-1372. (Pubitemid 29227522)
61. Kudo, S., K. Matsuno, T. Ezaki, and M. Ogawa. 1997. A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation. J. Exp. Med. 185: 777-784. (Pubitemid 27098161)
62. Uwatoku, R., M. Suematsu, T. Ezaki, T. Saiki, M. Tsuiji, T. Irimura, N. Kawada, T. Suganuma, M. Naito, M. Ando, and K. Matsuno. 2001. Kupffer cell-mediated recruitment of rat dendritic cells to the liver: roles of N-acetylgalactosamine-specific sugar receptors. Gastroenterology 121: 1460-1472. (Pubitemid 33140463)
63. Yoneyama, H., and T. Ichida. 2005. Recruitment of dendritic cells to pathological niches in inflamed liver. Med. Mol. Morphol. 38: 136-141. (Pubitemid 351543870)
64. Ellett, J. D., C. Atkinson, Z. P. Evans, Z. Amani, E. Balish, M. G. Schmidt, N. van Rooijen, R. G. Schnellmann, and K. D. Chavin. 2010. Murine Kupffer cells are protective in total hepatic ischemia/reperfusion injury with bowel congestion through IL-10. J. Immunol. 184: 5849-5858.
65. Stolz, D. B., M. A. Ross, A. Ikeda, K. Tomiyama, T. Kaizu, D. A. Geller, and N. Murase. 2007. Sinusoidal endothelial cell repopulation following ischemia/reperfusion injury in rat liver transplantation. Hepatology 46: 1464-1475. (Pubitemid 350155528)
66. Chou, H. S., C. C. Hsieh, H. R. Yang, L. Wang, Y. Arakawa, K. Brown, Q. Wu, F. Lin, M. Peters, J. J. Fung, et al. 2011. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology 53: 1007-1019.
67. Housset, C., D. C. Rockey, and D. M. Bissell. 1993. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc. Natl. Acad. Sci. USA 90: 9266-9270. (Pubitemid 23315764)
68. Gabriel, A., R. H. Kuddus, A. S. Rao, W. D. Watkins, and C. R. Gandhi. 1998. Superoxide-induced changes in endothelin (ET) receptors in hepatic stellate cells. J. Hepatol. 29: 614-627. (Pubitemid 28484951)
69. Gabriel, A., R. H. Kuddus, A. S. Rao, and C. R. Gandhi. 1999. Down-regulation of endothelin receptors by transforming growth factor beta1 in hepatic stellate cells. J. Hepatol. 30: 440-450. (Pubitemid 29113233)
70. Guruli, G., B. R. Pflug, S. Pecher, V. Makarenkova, M. R. Shurin, and J. B. Nelson. 2004. Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops. Blood 104: 2107-2115. (Pubitemid 39297865)
71. Sá-Nunes, A., A. Bafica, D. A. Lucas, T. P. Conrads, T. D. Veenstra, J. F. Andersen, T. N. Mather, J. M. Ribeiro, and I. M. Francischetti. 2007. Prostaglandin E2 is a major inhibitor of dendritic cell maturation and function in Ixodes scapularis saliva. J. Immunol. 179: 1497-1505.
72. Harizi, H., C. Grosset, and N. Gualde. 2003. Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes. J. Leukoc. Biol. 73: 756-763. (Pubitemid 38040454)
73. Diehl, L., A. Schurich, R. Grochtmann, S. Hegenbarth, L. Chen, and P. A. Knolle. 2008. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance. Hepatology 47: 296-305. (Pubitemid 351171067)
74. Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774. (Pubitemid 39336293)
75. Jung, I. D., M. G. Lee, J. H. Chang, J. S. Lee, Y. I. Jeong, C. M. Lee, W. S. Park, J. Han, S. K. Seo, S. Y. Lee, and Y. M. Park. 2009. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock. J. Immunol. 182: 3146-3154.
76. Gandhi, C. R., R. H. Kuddus, T. Uemura, and A. S. Rao. 2000. Endothelin stimulates transforming growth factor-beta1 and collagen synthesis in stellate cells from control but not cirrhotic rat liver. Eur. J. Pharmacol. 406: 311-318.
77. Iwamoto, N., H. Ito, K. Ando, T. Ishikawa, A. Hara, A. Taguchi, K. Saito, M. Takemura, M. Imawari, H. Moriwaki, and M. Seishima. 2009. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo. Liver Int. 29: 277-283.
78. Ito, H., M. Hoshi, H. Ohtaki, A. Taguchi, K. Ando, T. Ishikawa, Y. Osawa, A. Hara, H. Moriwaki, K. Saito, and M. Seishima. 2010. Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model. J. Immunol. 185: 4554-4560.
79. Beyth, S., Z. Borovsky, D. Mevorach, M. Liebergall, Z. Gazit, H. Aslan, E. Galun, and J. Rachmilewitz. 2005. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105: 2214-2219. (Pubitemid 40731815)
80. Gur-Wahnon, D., Z. Borovsky, M. Liebergall, and J. Rachmilewitz. 2009. The induction of APC with a distinct tolerogenic phenotype via contact-dependent STAT3 activation. PLoS ONE 4: e6846.
81. Bonifazi, P., T. Zelante, C. D'Angelo, A. De Luca, S. Moretti, S. Bozza, K. Perruccio, R. G. Iannitti, G. Giovannini, C. Volpi, et al. 2009. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol. 2: 362-374.
82. McLoughlin, R. M., B. J. Jenkins, D. Grail, A. S. Williams, C. A. Fielding, C. R. Parker, M. Ernst, N. Topley, and S. A. Jones. 2005. IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc. Natl. Acad. Sci. USA 102: 9589-9594. (Pubitemid 40981725)
83. Marra, F. 1999. Hepatic stellate cells and the regulation of liver inflammation. J. Hepatol. 31: 1120-1130.
84. Cheng, F., Y. Li, L. Feng, and S. Li. 2008. Hepatic stellate cell activation and hepatic fibrosis induced by ischemia/reperfusion injury. Transplant. Proc. 40: 2167-2170.
85. Cheng, Q., K. T. Ng, S. T. Fan, Z. X. Lim, D. Y. Guo, X. B. Liu, Y. Liu, R. T. Poon, C. M. Lo, and K. Man. 2010. Distinct mechanism of small-for-size fatty liver graft injury-Wnt4 signaling activates hepatic stellate cells. Am. J. Transplant. 10: 1178-1188.